NEW YORK (GenomeWeb News) – In a study appearing online today in Nature, researchers from the UK and the Czech Republic reported that they have been able to discern distinct estrogen receptor-binding sites — and related gene expression profiles — in ER-positive breast cancer genomes from individuals with poor or more positive clinical outcomes.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.